There were 1,867 press releases posted in the last 24 hours and 442,527 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
AIM ImmunoTech’s Subsidiary Receives Orphan Medicinal Product Designation by the European Medicines Agency for Ampligen to Treat Pancreatic Cancer

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image